Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence
Christopher N. Andrews, Renata Rehak, Matthew Woo, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 11-12, pp. 1532-1542
Closed Access | Times Cited: 17

Showing 17 citing articles:

AGA Clinical Practice Update on Diagnosis and Management of Cannabinoid Hyperemesis Syndrome: Commentary
Alberto Rubio‐Tapia, Richard W. McCallum, Michael Camilleri
Gastroenterology (2024) Vol. 166, Iss. 5, pp. 930-934.e1
Open Access | Times Cited: 13
Cannabinoids and the Gastrointestinal Tract
Michael Camilleri, Ting Zheng
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 13, pp. 3217-3229
Closed Access | Times Cited: 14
The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study
Hussain Jaafari, Lesley A. Houghton, Robert West, et al.
Neurogastroenterology & Motility (2023) Vol. 35, Iss. 6
Open Access | Times Cited: 13
Understanding youth and young adult cannabis use in Canada post-legalization: a scoping review on a public health issue
Toula Kourgiantakis, Ragave Vicknarajah, Judith Logan, et al.
Substance Abuse Treatment Prevention and Policy (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study
A. Marquette, Maryam Iraniparast, David Hammond
BMJ Open (2024) Vol. 14, Iss. 1, pp. e077908-e077908
Open Access | Times Cited: 2
Trends of emergency department visits for cannabinoid hyperemesis syndrome in Nevada: An interrupted time series analysis
Jae Seung Soh, Yonsu Kim, Jay J. Shen, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303205-e0303205
Open Access | Times Cited: 2
Cannabis use patterns and association with hyperemesis: A comprehensive review
William L. Hasler, Omayma Alshaarawy, Thangam Venkatesan
Neurogastroenterology & Motility (2024)
Open Access | Times Cited: 2
Rare but relevant: Cannabinoid hyperemesis syndrome
Daniel Stjepanović, Jennifer L. Kirkman, Wayne Hall
Addiction (2024)
Closed Access | Times Cited: 2
Cannabis Use Patterns and Whole-Blood Cannabinoid Profiles of Emergency Department Patients With Suspected Cannabinoid Hyperemesis Syndrome
Rachel Wightman, Jane Metrik, Timmy R. Lin, et al.
Annals of Emergency Medicine (2023) Vol. 82, Iss. 2, pp. 121-130
Open Access | Times Cited: 4
Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department
Rachel Wightman, Jane Metrik, Timmy Lin, et al.
Academic Emergency Medicine (2023) Vol. 31, Iss. 5, pp. 463-470
Open Access | Times Cited: 4
Reducing the harms of cannabis use in youth post-legalization: insights from Ontario youth, parents, and service providers
Toula Kourgiantakis, Angie Hamilton, Christine Tait, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Mental health adverse events with cannabis use diagnosed in the Emergency Department: what are we finding now and are our findings accurate?
Candice E. Crocker, Jason G. Emsley, Philip G. Tibbo
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 3
Fármacos enteógenos y la depresión resistente al tratamiento: Una revisión narrativa
Andrea Herrera-Solís, Jacqueline Cortés Morelos, Alejandra E. Ruíz-Contreras, et al.
PSICUMEX (2024) Vol. 14, pp. 1-34
Open Access
Changes in Cannabis-Related Health Care Use in Alberta After Cannabis Legalization Between 2018 and 2022: A Population-Based Interrupted Time Series Study
Mohammad Habibullah Pulok, Nirav P. Patel, Michelle Fry, et al.
International Journal of Mental Health and Addiction (2024)
Closed Access
Editorial: cannabis use disorders at the emergency department, a sign of a growing cannabinoid emergency
Hans Törnblom
Alimentary Pharmacology & Therapeutics (2022) Vol. 57, Iss. 1, pp. 148-148
Closed Access | Times Cited: 2
Exponentiated model of drug demand is preferred over exponential models in people with daily/near daily cannabis use.
Preston T Tolbert, Miranda Ramirez, Justin C. Strickland, et al.
Experimental and Clinical Psychopharmacology (2023) Vol. 31, Iss. 6, pp. 1010-1016
Open Access
Editorial: cannabis use disorders at the emergency department, a sign of a growing cannabinoid emergency—authors' reply
Christopher N. Andrews, Keith A. Sharkey
Alimentary Pharmacology & Therapeutics (2022) Vol. 57, Iss. 1, pp. 149-149
Closed Access
Page 1

Scroll to top